Article Text

Download PDFPDF

Ibuprofen and acute renal failure in a toddler
  1. N E Moghal1,
  2. S Hegde1,
  3. K M Eastham2
  1. 1Department of Paediatric Nephrology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
  2. 2Department of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
  1. Correspondence to:
    Dr N E Moghal
    Consultant Paediatric Nephrologist, Department of Paediatric Nephrology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Ibuprofen and paracetamol are equally effective1 and widely used antipyretic agents in paediatric practice. There is no evidence to support the concept that treating a fever with antipyretics, paracetamol, or ibuprofen, will prevent febrile convulsions.2 Ibuprofen is available over the counter and is used in addition to or instead of paracetamol both in hospital and community settings. It is advertised on television. There is an increasing trend to routinely prescribe both drugs for children specifically to manage fever. Although it is considered to be a reasonably safe drug,3 there are reports of nephrotoxicity,4,5 including renal failure when ibuprofen is administered to volume depleted children.6


A previously well, 18 month old, 10.5 kg boy presented with a four week history of intermittent cough and wheeze. In the week prior to admission he developed a fever, increasing lethargy, anorexia, and refusing to drink adequately. His fever was initially treated with paracetamol (5 ml (120 mg) up to four times a day), but with a persisting fever ibuprofen was then given in addition over the subsequent week at the correct dose (2.5 ml (50 mg), maximum six doses), until three days prior to admission, during which time he was noted to have increasingly dry nappies. On examination he was afebrile, sleepy but rousable, mildly dehydrated, with normal capillary refill and normal blood pressure (90 mm Hg systolic). He was mildly tachypnoeic (38 breaths/min) with scattered expiratory wheeze. Urinalysis showed 2+ protein, 1+ glucose, and no blood. Phase contrast microscopy revealed one mixed cellular cast but no cells or organisms. He was profoundly hyperkalaemic (potassium 8.7 mmol/l), acidotic (bicarbonate 12 mmol/l), and uraemic (urea 69.6 mmol/l, creatinine 523 μmol/l). Blood glucose was 9.2 mmol/l with subsequent normal values. A full blood count and film was normal except for a raised white cell count (21.6×109/l) with a predominant neutrophilia. C3 and C4 complement levels and an autoantibody profile were normal. A nasopharyngeal aspirate ultimately confirmed a respiratory syncytial virus infection to account for his cough and wheeze.

Following appropriate emergency management of the hyperkalaemia, peritoneal dialysis was commenced and continued for six days. An ultrasound scan 12 hours after admission showed large (>95th centile) echogenic kidneys with reduced corticomedullary differentiation but no obstruction.

A renal biopsy was done four days after admission. The 17 glomeruli identified were all normal. There was marked interstitial oedema. The tubules showed marked epithelial attenuation with nuclear pleomorphism and mitotic activity, in keeping with extensive acute tubular necrosis. The blood vessels were normal. Immunofluoresence was negative for immune proteins.

One year follow up has revealed a slightly depressed glomerular filtration rate at 75 ml/min/1.73m2 (Schwarz formula). A DMSA scan was normal but an ultrasound scan showed localised cortical loss in the left kidney. This suggests that the renal ischaemia was sufficient to cause a mild degree of cortical necrosis. He is currently normotensive.


Non-steroidal anti-inflammatory agents, including ibuprofen, reduce the renal synthesis of prostaglandins by inhibiting the enzyme cyclooxygenase. In a euvolaemic state prostaglandins have a negligible effect on renal haemodynamics. Where there is ineffective circulating plasma volume, there is an up-regulation of the renin-angiotensin system as well as increased catecholamine release, which in addition to producing renal vasoconstriction also stimulates renal prostaglandin production. These prostaglandins counteract the vasoconstrictor effect by decreasing the pre-glomerular resistance and thereby maintain renal perfusion and glomerular filtration. This protective effect is inhibited by the administration of ibuprofen, resulting in unopposed renal vasoconstriction, leading to renal failure. Animal data suggest that the immature kidney is particularly vulnerable to these effects.7

Young children with pyrexia are at an increased risk of dehydration as they may be unwilling or unable to drink, may not have access to water, and have an increased insensible loss due to relatively greater body surface area. Milder degrees of dehydration can be difficult to detect in these children or may go unnoticed, at home, under primary care supervision, or even in an inpatient setting. Clinical states change and a child who is initially only febrile may later have additional losses such as diarrhoea and vomiting. Prescribing ibuprofen where there is, or there is the potential for, volume depletion is therefore not without risk.

The patient information sheet for ibuprofen lacks advice on the importance of maintaining good fluid intake and hydration when taking ibuprofen and makes no mention of the rare but serious side effect of acute renal failure. We would recommend that ibuprofen be avoided in infants and toddlers for the management of pyrexia where the child is dehydrated or could potentially become dehydrated during the course of an illness. Paracetamol is an effective antipyretic agent when used in adequate doses.



  • Competing interests: none